دورية أكاديمية

336P PI3K pathway biomarkers and clinical response in a phase I/Ib study of GDC-0077 in hormone receptor-positive/HER2-negative breast cancer (HR+/HER2– BC)

التفاصيل البيبلوغرافية
العنوان: 336P PI3K pathway biomarkers and clinical response in a phase I/Ib study of GDC-0077 in hormone receptor-positive/HER2-negative breast cancer (HR+/HER2– BC)
المؤلفون: Gambardella, V., Cervantes, A., Bedard, P.L., Hamilton, E.P., Italiano, A., Jhaveri, K., Juric, D., Kalinsky, K., Krop, I.E., Oliveira, M., Saura, C., Schmid, P., Turner, N., Varga, A., Liu, B.P., Chen, J.W., Aimi, J., Royer-Joo, S., Schutzman, J.L., Hutchinson, K.E.
المصدر: In Annals of Oncology September 2020 31 Supplement 4:S381-S382
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2020.08.438